NCT02157766

Brief Summary

The Wisconsin Center for the Neuroscience and Psychophysiology of Meditation will be a highly focused center dedicated to novel and cutting edge research on the mechanisms by which meditation works. The core set of hypotheses for this Center focus on the mechanisms of two common meditation practices: Mindfulness Meditation (MM) and Loving-Kindness/Compassion Meditation (LKM-CO), both taught in Mindfulness-Based Stress Reduction (MBSR). The investigators will study both Long-Term Meditators (LTMs) as well as meditation-naïve participants (MNPs). The latter group will be randomly assigned to MBSR, a rigorously matched comparison intervention called the Health Enhancement Program (HEP; MacCoon et al., 2012), or to a Wait List (WL) control group. This will give us a comprehensive view of changes that are produced by meditation practices per se, changes generically associated with interventions designed to promote well-being, and changes that might be effects of repeating testing protocols across multiple occasions. In addition, the inclusion of both novice and experienced meditators provides a wide range of practice experience that will provide critical information on dose-related effects, information that is lacking in the research literature today. Each of the projects is focused on examining the brain mechanisms and peripheral biological correlates of meditation. Project 1 (Davidson) will examine the impact of the explicit use of mindfulness and loving-kindness/compassion strategies on emotion regulation, specifically neural, biobehavioral and hormonal indices of reactivity to and recovery from pictures of human suffering and flourishing. Project 2 (Rosenkranz) will investigate the brain to periphery pathways through which psychological factors contribute to the expression of asthma symptoms. In addition, it will examine the efficacy of meditation training in reducing the inflammatory response to an allergen in asthmatic individuals by reducing the reactivity of emotion-related neural circuitry. Project 3 (Tononi) will examine whether the previously reported increase in gamma oscillations during Non-REM (NREM) sleep in meditators is associated with changes in sleep mentation (Ferrarelli et al. 2013). In addition, project 3 will examine relations between meditation-induced changes in brain activity during sleep and brain activity and cognitive function during wakefulness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
457

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2014

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 6, 2014

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2019

Completed
Last Updated

August 3, 2021

Status Verified

May 1, 2019

Enrollment Period

4.2 years

First QC Date

May 27, 2014

Last Update Submit

July 27, 2021

Conditions

Keywords

Mental HealthAsthmaMindfulnessCompassionMeditation

Outcome Measures

Primary Outcomes (3)

  • Change in temporal dynamics of response to emotional anticipation task (fMRI) as a result of short term meditation practice OR 8 week training in meditation or health wellness interventions.

    baseline, 3 months, 10 months

  • Change in slope measure of diurnal cortisol following a well-being intervention relative to baseline.

    baseline (pre-intervention), 3 months (post-intervention), 10 months (follow-up)

  • Difference between groups (MBSR, WL) on change in lung function from pre-training to post-training

    baseline (pre), 3 months (post-intervention)

Study Arms (6)

MNP with Asthma: Mindfulness Based Stress Reduction

ACTIVE COMPARATOR
Behavioral: Mindfulness Based Stress Reduction

MNP w/ Asthma: Wait List Control

NO INTERVENTION

MNP, no asthma - Mindfulness Based Stress Reduction

ACTIVE COMPARATOR
Behavioral: Mindfulness Based Stress Reduction

MNP, no asthma: Health Enhancement Program

ACTIVE COMPARATOR
Behavioral: Health Enhancement Program

MNP, no asthma - Wait List Control

NO INTERVENTION

Long Term Meditator

ACTIVE COMPARATOR
Behavioral: Intensive Meditation Practice

Interventions

Long term meditators complete three days of of mindfulness or compassion/loving kindness meditation at T2 and T3 (one meditation type per visit).

Long Term Meditator

8 week class designed to enhance well-being through training in mindfulness.

Also known as: MBSR
MNP with Asthma: Mindfulness Based Stress ReductionMNP, no asthma - Mindfulness Based Stress Reduction

8 week class designed to enhance well-being through training in physical activity, functional movement, music therapy and nutrition.

Also known as: HEP
MNP, no asthma: Health Enhancement Program

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to provide valid informed consent to participate by signing/dating a consent form.
  • Fluent English speaker
  • MRI safe - Not excluded based on magnetic resonance Screening Form
  • years old
  • Pre-albuterol FEV1 ≥ 60% while holding meds
  • Physician's diagnosis of asthma - via clinical assessment, reversibility or airway hyperresponsivity;
  • Ability to provide blood samples with relatively easy vascular access
  • Uses acceptable contraception
  • Evidence of persistent, residual inflammation (≥2% sputum eosinophils OR peripheral blood eosinophils ≥ 150 OR eNO of 30+
  • Must be US citizen, green card holder or have an F-1 or J-1 visa. This is required in order to be able to pay participants.

You may not qualify if:

  • Pregnant, wanting to become pregnant, breast feeding or less than 6 months post-partum.
  • Taking prescribed psychotropic or central nervous system altering medications (may be included with the PIs discretion).
  • History of a diagnosed Bipolar Disorder, Schizophrenia, or Schizoaffective Disorder. Diagnosed episode of Major Depression unless it was more than 1 year ago. Diagnosed eating disorder or anxiety disorder unless it was more than 1 year ago. (May be included with the PIs discretion).
  • Excluded based upon the screening visit
  • Some ongoing medical problems will be excluded based on team judgments about whether they will affect a participant's ability to participate in the study procedures or will affect one or more outcome measures.
  • Unable to distinguish colors used in Stroop task
  • Use of oral corticosteroids
  • Inability or unwillingness to withhold medication as detailed below, before each set of laboratory assessments:
  • Leukotriene Inhibitors - 2 days
  • Zyrtec - 5 days
  • Allegra/Claritin - 4 days
  • Antihistamines - 2 days
  • Nasal Steroids - 24h
  • Albuterol - 6 h
  • Inhaled corticosteroids - 12 h
  • +66 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

UW Madison, Center for Investigating Healthy Minds at the Waisman Center

Madison, Wisconsin, 53705, United States

Location

UW-Madison, Asthma, Allergy and Pulmonary Research Center

Madison, Wisconsin, 53705, United States

Location

UW-Health Sports Medicine & Integrative Medicine Program

Madison, Wisconsin, 53711, United States

Location

Center for Sleep and Consciousness (and Wisconsin Sleep Clinic)

Madison, Wisconsin, 53719, United States

Location

Related Publications (1)

  • Higgins ET, Davidson RJ, Busse WW, Klaus DR, Bednarek GT, Goldman RI, Sachs J, Rosenkranz MA. Clinically relevant effects of Mindfulness-Based Stress Reduction in individuals with asthma. Brain Behav Immun Health. 2022 Sep 14;25:100509. doi: 10.1016/j.bbih.2022.100509. eCollection 2022 Nov.

MeSH Terms

Conditions

Psychological Well-BeingAsthma

Interventions

Mindfulness-Based Stress Reduction

Condition Hierarchy (Ancestors)

Personal SatisfactionBehaviorBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Richard J Davidson, PhD

    UW-Madison, Center for Investigating Healthy Minds at the Waisman Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2014

First Posted

June 6, 2014

Study Start

September 1, 2014

Primary Completion

November 1, 2018

Study Completion

April 14, 2019

Last Updated

August 3, 2021

Record last verified: 2019-05

Locations